Literature DB >> 8878534

Molecular cloning and characterization of the human transmembrane protein tyrosine phosphatase homologue, phogrin, an autoantigen of type 1 diabetes.

E Kawasaki1, J C Hutton, G S Eisenbarth.   

Abstract

A 4.7 kb cDNA of tyrosine phosphatase-like protein, phogrin, was isolated from a human islet cDNA library. Sequencing of the resulting clone identified a 3,045 residue open-reading frame encoding a 1,015 amino acid polypeptide with predicted molecular mass of 111,303 daltons. Phogrin's amino acid sequence has a single transmembrane region and one putative tyrosine phosphatase catalytic domain. Phogrin is 74% identical to the ICA512/IA-2 autoantigen of type 1 diabetes in the cytoplasmic domain, but only 29% in the luminal domain. It showed > 90% identity to rat phogrin and mouse IA-2 beta. Autoantibody radioassays utilizing full-length and the cytoplasmic domain of phogrin were compared. With positivity defined above the 99th percentile of 105 normal control subjects, 37 (48%) and 47 (61%) of sera from 77 new-onset patients with type 1 diabetes were positive for autoantibodies to full-length and the cytoplasmic domain of phogrin, respectively. The assay utilizing cytoplasmic human phogrin gave higher sensitivity with identical specificity to the assay utilizing the full-length molecule primarily due to lower "background" binding. Phogrin is an additional major autoantigen for type 1 diabetes and the isolation of the cDNA of this molecule from human islets will aid in studies of the pathogenesis of type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878534     DOI: 10.1006/bbrc.1996.1526

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Novel biomarkers in type 1 diabetes.

Authors:  Yulan Jin; Jin-Xiong She
Journal:  Rev Diabet Stud       Date:  2012-12-28

2.  Association of genetic variants with chronic kidney disease in Japanese individuals with or without hypertension or diabetes mellitus.

Authors:  Tetsuro Yoshida; Kimihiko Kato; Kiyoshi Yokoi; Mitsutoshi Oguri; Sachiro Watanabe; Norifumi Metoki; Hidemi Yoshida; Kei Satoh; Yukitoshi Aoyagi; Yoshinori Nozawa; Yoshiji Yamada
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

3.  DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease.

Authors:  Laura J Smyth; Gareth J McKay; Alexander P Maxwell; Amy Jayne McKnight
Journal:  Epigenetics       Date:  2013-11-19       Impact factor: 4.528

4.  Mannose 6-phosphate receptors are sorted from immature secretory granules via adaptor protein AP-1, clathrin, and syntaxin 6-positive vesicles.

Authors:  J Klumperman; R Kuliawat; J M Griffith; H J Geuze; P Arvan
Journal:  J Cell Biol       Date:  1998-04-20       Impact factor: 10.539

5.  Excitatory and Inhibitory Neurons in the Hippocampus Exhibit Molecularly Distinct Large Dense Core Vesicles.

Authors:  José J Ramírez-Franco; Francisco J Munoz-Cuevas; Rafael Luján; Sandra Jurado
Journal:  Front Cell Neurosci       Date:  2016-08-31       Impact factor: 5.505

Review 6.  T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes.

Authors:  Adam L Burrack; Tijana Martinov; Brian T Fife
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-05       Impact factor: 5.555

7.  The association of genetically controlled CpG methylation (cg158269415) of protein tyrosine phosphatase, receptor type N2 (PTPRN2) with childhood obesity.

Authors:  Suman Lee
Journal:  Sci Rep       Date:  2019-03-19       Impact factor: 4.379

Review 8.  Are Alterations in DNA Methylation Related to CKD Development?

Authors:  Jacek Rysz; Beata Franczyk; Magdalena Rysz-Górzyńska; Anna Gluba-Brzózka
Journal:  Int J Mol Sci       Date:  2022-06-26       Impact factor: 6.208

9.  George S. Eisenbarth: insulin and type 1 diabetes.

Authors:  Alberto Pugliese; Jay S Skyler
Journal:  Diabetes Care       Date:  2013-06       Impact factor: 19.112

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.